Skip to main content
Premium Trial:

Request an Annual Quote

New NetGenics Synergy Version Enables Sharing

Premium

CLEVELAND--NetGenics has released an enhanced version of its Synergy application framework for drug discovery, featuring the ability to work with Incyte Pharmaceuticals' sequence data and "Distributed Synergy," which enables transparent, real-time data sharing among research teams at multiple sites. "With this release we have achieved our vision of providing an enterprise-scale computing infrastructure for drug discovery," said Manuel Glynias, NetGenics' president and CEO. In addition to demonstrating fully integrated, multisite capability, Glynias said the new version incorporates "some of the industry's most useful data sources and tools, exemplifying the ability of Synergy to provide best-of-breed solutions for pharmaceutical research computing."

The company said that the enhanced product allows users to retrieve, analyze, and annotate LifeSeq sequences without altering native data. It also enables scientists at different sites to have access to tools that were previously unavailable due to geographic separation. Other additions to the product, according to the company, include enhanced bioinformatics functionality, automated nightly updates of GenBank, weekly updates of Swiss-Prot, inclusion of the National Center for Biotechnology Information's Blast 2.0 and Smith Waterman analysis, and improvements to the framework's user interface.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.